This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Kate Fynes
Investigator, Cell & Gene Therapy Product Development at GlaxoSmithKline


Kate graduated from the Biochemical Engineering department of University College London with a PhD in Stem Cell Bioprocessing, before undertaking a Postdoctoral position at the Institute of Ophthalmology. Here, as part of The London Project, she helped deliver an embryonic-stem cell derived-ATMP to treat age-related Macular Degeneration from the bench to the clinic as part of a Phase I/II clinical trial.

She joined GSK’s Cell & Gene Therapy - Product Development team in 2017, where she works to deliver the CMC aspects of various projects from early phase to launch. Kate specializes in Cell Process Development, seeking to optimize the manufacture of cell and gene therapy-based treatments, using increased automation and leading-edge processing technology.

Kate Fynes's Network

Agenda Sessions

  • Large scale manufacturing for T- cell therapies using the CliniMACS prodigy


Speakers at this event